Oral administration of type-II collagen peptide 250–270 suppresses specific cellular and humoral immune response in collagen-induced arthritis
- 31 January 2007
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology
- Vol. 122 (1), 75-84
- https://doi.org/10.1016/j.clim.2006.08.004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pathogenesis of collagen-induced arthritis: modulation of disease by arthritogenic T-cell epitope locationImmunology, 2004
- Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetesDiabetes/Metabolism Research and Reviews, 2002
- The Influence of HLA-DR4 (0401) on the Immune Response to Type II Collagen and the Development of Collagen Induced Arthritis in MiceJournal of Autoimmunity, 2002
- Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 miceImmunology, 1998
- Enumeration of lymphokine‐secreting cells as a quantitative measure for cellular immune responses in rhesus macaquesJournal of Medical Primatology, 1995
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagenInflammation Research, 1986
- Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates.The Journal of Experimental Medicine, 1981
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980
- Autoimmunity to type II collagen an experimental model of arthritis.The Journal of Experimental Medicine, 1977